Synthesis of furo[2,3-c]pyran-β-D-thymidine

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 15, 1996, Pages 1815-1818

  Bousquie I ^a   Madiot, V ^a   Florent, J C ^a   Monneret, C ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NUCLEOSIDE DERIVATIVE; THYMIDINE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030572479     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00322-8     Document Type: Article

References (31)

1. 1) De Clercq, E. J. Med. Chem. 1995, 38, 2505 and references cited therein.
2. 2) a) Mitsuya, H.; Yarchoan, R.; Broder S. Science 1990, 249, 1553.
3. b) De Clercq, E.; Van Aerschot, A.; Herdewijn, P.; Baba, M.; Pauwels, R.; Balzarini, J. Nucleosides & Nucleotides 1989, 8, 659.
4. c) De Clercq, E. in "Design of Anti-Aids Drugs", De Clercq Editor, Pharmacochemistry Library, vol. 14, pp. 1-24, Elsevier (Amsterdam) 1990.
5. 3) Sommadossi, J.-P.; Carlisle, R. Antimicrob. Agents Chemother. 1987, 31, 452.
6. 4) a) Mann, J.; Tench, A.; Weymouth-Wilson, A.; Shaw-Ponter, S.; Young, R. J. Chem. Soc., Perkin Trans. I. 1995, 677.
7. b) Bamford, M.J.; Coe, P.L.; Walker, R.T. J. Med. Chem. 1990, 33, 2488.
8. c) Tseng, C.K.-H.; Marquez, V.E.; Milne, G.W.A.; Wysocki, R.J.; Mitsuya, H.; Shirasaki, T.; Driscoll, J.S. J. Med. Chem. 1991, 34, 343.
9. d) Svansson, L.; Kvarnström, I.; Classon, B.; Samuelsson B. Nucleosides & Nucleotides 1992, 11, 1353.
10. e) Czernecki, S.; Ezzitouni, A. J. Org. Chem. 1992, 57, 7325.
11. f) Xi, Z.; Agback, P.; Plavec, J.; Sandström, A.; Chattopadhyaya, J. Tetrahedron 1992, 48, 349.
12. 5) Surzhykofand S.A.; Krayevsky A. Nucleosides & Nucleotides 1994,13 (10), 2283-2305.
13. 6) a) Koole, L.H.; Neidle, S.; Crawford, M.D.; Krayevshi, A.A.; Gurskaya, G.V.; Sandström, A.; Wu, J.C.; Tong, W.; Chattopadhyaya, J. J. Org. Chem. 1991, 56, 6884.;
14. b) Thibaudeau, C.; Plâcec, J.; Garg, N.; Papchikhin, A.; Chattopadhyaya, J. J. Am. Chem. Soc. 1994, 116, 4038.
15. 7) Maag, H.; Nelson, J.T.; Rios Steiner, J.L.; Prisbé, E.J. J. Med. Chem. 1994, 37, 431.
16. 8) Alvarez, R.; Velasquez, S.; San-Felix, A.; Aquaro, S.; De Clercq, E.; Perno, C.; Karlsson, A.; Balzarini, J.; Camarasa, M.J. J. Med. Chem. 1994, 37, 4185.
17. 9) Yang, C.O.; Kurz, W.; Eugui, E.M.; McRoberts, M.J.; Verheyden, J.P.H.; Kurz, L.J.; Walker, K.A.M. Tetrahedron Lett. 1992, 33, 41.
18. 10) a) Krayevsky, M.A.; Watanabe, K.A. Nucleosides & Nucleotides 1993, 12 (6), 649.
19. b) Pratap, R.; Gulati, D.; Bhakuni, D.S.; George, C.X. Bioorg. Med. Chem. Lett. 1993, 3, 1661.
20. c) Altmann, K.H.; Kesselring, R.; Francotte, E.; Rihs, G. Tetrahedron Lett. 1994, 15, 2331.
21. g) Altmann, K.H., Imwinkelried, R.; Kesselring, R.; Rihs, G. Tetrahedron Lett. 1995, 36, 7375.
22. 11) For other [2,3-c]-pyran derivatives of β-D-thymidine, see: Xi, Z.; Agback, P., Sandström, A.; Chattopadhyaya, J. Tetrahedron 1991, 47, 9675.
23. 12) a) Chu, C.K.; Doboszewki, B.; Schmidt, W.; Ullas, G.V. J. Org. Chem. 1989, 54, 2767.
24. b) Fiandor, J.; Tam, S.Y. Tetrahedron Lett. 1992, 31, 597.
25. 13) Mancuso, A.J.; Swern, D. Synthesis 1981, 165.
26. 14) Jones, G.H.; Tanigushi, M.; Tegg, D.; Moffatt, J.G. J. Org. Chem. 1979, 44, 1309.
27. 15) Dess, D.B.; Martin, J.C. J. Am. Chem. Soc. 1991, 113, 7277.
28. 16) Montgomery, J.A.; Thomas, H.J. J. Org. Chem. 1981, 46, 594.
29. 17) Youssefyeh, R.; Tegg, D.; Verheiden, J.P.H.; Jones, G.H.; Moffatt, J.G. Tetrahedron Lett. 1977, 18, 435 .
30. +; 188; 171; 127.
31. 19) Maag, C.; Wick, A.; Le Ber, P.; Kirn, A.; Aubertin, A.-M. Antiviral Res. 1994, 24, 275.